Portfolio concentration
As of February 28, 2026 · N-PORT
Holdings
56
Top-10 weight
43.83%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
34
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
653.8
Holdings
As of February 28, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | — | 98,581 | $10.06M | 6.29% |
| 2 | Novartis AG (Registered) | NVSEF | 46,684 | $7.92M | 4.96% |
| 3 | BRIDGEBIO PHARMA INC | — | 114,318 | $7.60M | 4.75% |
| 4 | ASTRAZENECA PLC | — | 35,320 | $7.40M | 4.63% |
| 5 | LILLY ELI and CO | — | 6,565 | $6.91M | 4.32% |
| 6 | BRISTOL-MYERS SQUIBB CO | — | 108,187 | $6.75M | 4.22% |
| 7 | Roche Holding AG | — | 108,952 | $6.49M | 4.06% |
| 8 | MERCK & CO | — | 49,630 | $6.15M | 3.84% |
| 9 | ARCELLX INC | — | 48,346 | $5.50M | 3.44% |
| 10 | COGENT BIOSCIENCES INC | — | 135,358 | $5.26M | 3.29% |
| 11 | NUVALENT INC-A | — | 49,239 | $5.02M | 3.14% |
| 12 | GENMAB A/S -SP ADR DEPOSITARY RECEIPT | GMAB | 169,724 | $5.00M | 3.13% |
| 13 | IMMUNOME INC | — | 195,451 | $4.27M | 2.67% |
| 14 | JOHNSON&JOHNSON | — | 16,257 | $4.04M | 2.53% |
| 15 | CELCUITY INC | — | 35,371 | $3.95M | 2.47% |
| 16 | AMGEN INC | — | 10,122 | $3.93M | 2.46% |
| 17 | ABBVIE INC | — | 16,712 | $3.88M | 2.43% |
| 18 | EXELIXIS INC | — | 79,639 | $3.51M | 2.19% |
| 19 | IDEAYA BIOSCIENCES | — | 89,238 | $2.87M | 1.80% |
| 20 | BEONE MEDICINES LTD ADR | — | 8,960 | $2.84M | 1.78% |
| 21 | SYNDAX PHARMACEUTICALS INC | — | 127,353 | $2.76M | 1.73% |
| 22 | CG ONCOLOGY INC | — | 45,885 | $2.70M | 1.69% |
| 23 | ZAI LAB LTD UNSPNRD ADR | — | 121,279 | $2.33M | 1.46% |
| 24 | ERASCA INC | — | 169,487 | $2.32M | 1.45% |
| 25 | ZYMEWORKS INC | — | 96,723 | $2.25M | 1.41% |
| 26 | LEGEND BIOTECH CORP SPON ADR | — | 115,409 | $2.19M | 1.37% |
| 27 | NUVATION BIO INC | — | 362,046 | $2.14M | 1.34% |
| 28 | HALOZYME THERAPEUTICS INC | — | 29,868 | $2.08M | 1.30% |
| 29 | CHUGAI PHARMA CO | — | 30,652 | $2.05M | 1.28% |
| 30 | SUMMIT THERAPEUTICS INC | — | 110,918 | $1.84M | 1.15% |
| 31 | ANAPTYSBIO INC | — | 28,657 | $1.58M | 0.99% |
| 32 | NURIX THERAPEUTICS INC | — | 97,555 | $1.56M | 0.97% |
| 33 | REGENERON PHARMACEUTICALS INC | — | 1,982 | $1.55M | 0.97% |
| 34 | CORVUS PHARMACEUTICALS INC | — | 82,148 | $1.50M | 0.94% |
| 35 | UROGEN PHARMA LTD | URGN | 67,164 | $1.46M | 0.91% |
| 36 | RELAY THERAPEUTICS INC | — | 142,040 | $1.46M | 0.91% |
| 37 | GILEAD SCIENCES INC | — | 9,272 | $1.38M | 0.86% |
| 38 | OLEMA PHARMACEUTICALS INC | — | 56,608 | $1.37M | 0.86% |
| 39 | DAY ONE BIOPHARMACEUTICALS INC | — | 121,928 | $1.29M | 0.81% |
| 40 | ARGENX SE SPONSORED ADR | — | 1,663 | $1.28M | 0.80% |
| 41 | TERNS PHARMACEUTICALS INC | — | 28,018 | $1.18M | 0.74% |
| 42 | FIRST AM-TR OB-X | TMPXX | 1,026,901 | $1.03M | 0.64% |
| 43 | XENCOR INC | — | 76,928 | $982.37K | 0.61% |
| 44 | TYRA BIOSCIENCES INC | — | 28,438 | $947.27K | 0.59% |
| 45 | GUARDANT HEALTH INC | — | 10,008 | $939.75K | 0.59% |
| 46 | ARCUS BIOSCIENCES INC | — | 45,953 | $936.06K | 0.59% |
| 47 | ARRIVENT BIOPHARMA INC | — | 40,743 | $935.87K | 0.59% |
| 48 | Immunocore Holdings plc ADS | IMCR US | 28,275 | $913.28K | 0.57% |
| 49 | HUTCHMED CHINA LTD ADR | HCM | 62,129 | $890.31K | 0.56% |
| 50 | MONTE ROSA THERAPEUTICS INC | — | 45,524 | $808.05K | 0.51% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.